Clinical Research Directory
Browse clinical research sites, groups, and studies.
Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine
Sponsor: Theis S. Itenov
Summary
The primary objective of the IMPACT-NAC trial is to assess the effects of N-acetylcysteine on survival and hospital length of stay in adults admitted to the emergency department with acute infection or sepsis and evidence of liver dysfunction. The main question it aims to answer is: does N-acetylcysteine increase the number of days alive and out of the hospital within the first 14 days after enrolment in the trial? To answer this question, we will conduct a randomized, double-blinded controlled trial of 360 participants. Participants will be randomized to either N-acetylcysteine or placebo (normal saline without active drugs). This will be administered as an infusion during four hours within the first day of hospital admission.
Official title: A Randomized, Placebo-controlled, Blinded, Parallel-group Clinical Trial to Assess the Efficacy of N-acetylcysteine in Adults With Acute Infections or Sepsis and Evidence of Liver Dysfunction: the IMPACT-NAC Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
360
Start Date
2026-07
Completion Date
2028-05
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
N-Acetylcysteine (NAC) Treatment
Intravenous infusion of N-acetylcysteine (200 mg/kg mixed with normal saline to a final volume of 500 ml) administered over four hours.
Locations (1)
Department of Emergency Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg
Copenhagen, Denmark